Effect of Omalizumab (Xolair) on Basophils in Patients With Chronic Idiopathic Urticaria

Summary

This study looks at changes in cell proteins in people with chronic hives treated with omalizumab.

Timeline

Start

2013-04

Primary completion

2016-04

Completion

2017-10

Publications

• Results Stitt JM, Dzieciatkowska M, Edwards MG, Hansen K, Hedlund G, Dreskin SC. The basophil proteome in chronic spontaneous urticaria distinguishes responders to omalizumab from non-responders. Clin Exp Allergy. 2018 Jul;48(7):898-901. doi: 10.1111/cea.13149. Epub 2018 May 20. No abstract available.

Drugs

Indications